Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125446801 | 12544680 | 1 | I | 20160705 | 20160707 | 20160711 | 20160711 | PER | US-PFIZER INC-2016336257 | PFIZER | 31.00 | YR | F | Y | 56.70000 | KG | 20160711 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125446801 | 12544680 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | THREE 75MG CAPSULES BY MOUTH A DAY | 20699 | 225 | MG | PROLONGED-RELEASE CAPSULE | |||||||
| 125446801 | 12544680 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | THREE 75MG CAPSULES BY MOUTH A DAY | 20699 | 225 | MG | PROLONGED-RELEASE CAPSULE |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125446801 | 12544680 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125446801 | 12544680 | Abdominal pain upper | |
| 125446801 | 12544680 | Diarrhoea | |
| 125446801 | 12544680 | Headache | |
| 125446801 | 12544680 | Nausea | |
| 125446801 | 12544680 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125446801 | 12544680 | 1 | 2011 | 0 | ||
| 125446801 | 12544680 | 2 | 20160704 | 0 |